Key result
Indomethacin exposure in fetuses resulted in normal echocardiograms in 74% of cases, with temporary tricuspid valve regurgitation and ductal constriction as the most common side effects.
Why the study?
What are the fetal echocardiographic findings and safety profile of indomethacin treatment in exposed fetuses?
Observational (n=107)
What are the fetal echocardiographic findings and safety profile of indomethacin treatment in exposed fetuses?
Indomethacin treatment is relatively safe for the fetal heart, with tricuspid regurgitation and temporary ductal constriction being the most common side effects that do not necessarily contraindicate continued use.
Answers are grounded in this paper and cite their sources.
Indomethacin exposure was associated with mostly normal fetal echoes; leaves open whether routine monitoring improves outcomes in indicated tocolysis.
Fetal echocardiograms were evaluated in 315 studies performed in 107 fetuses exposed to indomethacin. In the majority of cases, the results of the fetal echocardiography study were within normal limits (74%). The most common abnormal phenomena were tricuspid valve regurgitation (10%), ductal constriction (6%), tricuspid valve regurgitation and ductal constriction (5%), an increased ductal velocity (2%), and other (3%). The difference between the prevalence of ductal constriction in the whole series of studies (11%) compared to the prevalence of ductal constriction per fetus (25%) (p < 0.001) suggests that this phenomenon was only temporary and disappeared when medication was discontinued. The mean gestational age for detection of tricuspid valve regurgitation was 27.7 +/- 2.8 weeks and for ductal constriction, 30.9 +/- 2.1 weeks (t-test, p < 0.01). Trivial tricuspid valve regurgitation was detected at a mean of 26.7 +/- 2.2 weeks and significant tricuspid valve regurgitation at 29.6 +/- 2.3 weeks (t-test, p < 0.01). We conclude that indomethacin treatment is relatively safe for the fetal heart. The most common side-effects are tricuspid valve regurgitation and ductal constriction. Tricuspid valve regurgitation may be detected before ductal constriction, but by itself it is not a contraindication for the continued use of indomethacin.
No takes yet. Share an insight, caveat, or question.
Respondek et al. (1995) conducted an observational in Fetuses exposed to indomethacin (n=107). Indomethacin was evaluated on Fetal echocardiography findings. Indomethacin exposure in fetuses resulted in normal echocardiograms in 74% of cases, with temporary tricuspid valve regurgitation and ductal constriction as the most common side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: